F

Fresenius Medical Care AG & Co KGaA
XETRA:FME

Watchlist Manager
Fresenius Medical Care AG & Co KGaA
XETRA:FME
Watchlist
Price: 42.25 EUR 1.95% Market Closed
Market Cap: 12.4B EUR
Have any thoughts about
Fresenius Medical Care AG & Co KGaA?
Write Note

Intrinsic Value

The intrinsic value of one FME stock under the Base Case scenario is 80.86 EUR. Compared to the current market price of 42.25 EUR, Fresenius Medical Care AG & Co KGaA is Undervalued by 48%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

FME Intrinsic Value
80.86 EUR
Undervaluation 48%
Intrinsic Value
Price
F
Worst Case
Base Case
Best Case

Valuation Backtest
Fresenius Medical Care AG & Co KGaA

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for FME cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about FME?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Fresenius Medical Care AG & Co KGaA

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Fresenius Medical Care AG & Co KGaA

Provide an overview of the primary business activities
of Fresenius Medical Care AG & Co KGaA.

What unique competitive advantages
does Fresenius Medical Care AG & Co KGaA hold over its rivals?

What risks and challenges
does Fresenius Medical Care AG & Co KGaA face in the near future?

Has there been any significant insider trading activity
in Fresenius Medical Care AG & Co KGaA recently?

Summarize the latest earnings call
of Fresenius Medical Care AG & Co KGaA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Fresenius Medical Care AG & Co KGaA.

Provide P/S
for Fresenius Medical Care AG & Co KGaA.

Provide P/E
for Fresenius Medical Care AG & Co KGaA.

Provide P/OCF
for Fresenius Medical Care AG & Co KGaA.

Provide P/FCFE
for Fresenius Medical Care AG & Co KGaA.

Provide P/B
for Fresenius Medical Care AG & Co KGaA.

Provide EV/S
for Fresenius Medical Care AG & Co KGaA.

Provide EV/GP
for Fresenius Medical Care AG & Co KGaA.

Provide EV/EBITDA
for Fresenius Medical Care AG & Co KGaA.

Provide EV/EBIT
for Fresenius Medical Care AG & Co KGaA.

Provide EV/OCF
for Fresenius Medical Care AG & Co KGaA.

Provide EV/FCFF
for Fresenius Medical Care AG & Co KGaA.

Provide EV/IC
for Fresenius Medical Care AG & Co KGaA.

Show me price targets
for Fresenius Medical Care AG & Co KGaA made by professional analysts.

What are the Revenue projections
for Fresenius Medical Care AG & Co KGaA?

How accurate were the past Revenue estimates
for Fresenius Medical Care AG & Co KGaA?

What are the Net Income projections
for Fresenius Medical Care AG & Co KGaA?

How accurate were the past Net Income estimates
for Fresenius Medical Care AG & Co KGaA?

What are the EPS projections
for Fresenius Medical Care AG & Co KGaA?

How accurate were the past EPS estimates
for Fresenius Medical Care AG & Co KGaA?

What are the EBIT projections
for Fresenius Medical Care AG & Co KGaA?

How accurate were the past EBIT estimates
for Fresenius Medical Care AG & Co KGaA?

Compare the revenue forecasts
for Fresenius Medical Care AG & Co KGaA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Fresenius Medical Care AG & Co KGaA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Fresenius Medical Care AG & Co KGaA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Fresenius Medical Care AG & Co KGaA compared to its peers.

Compare the P/E ratios
of Fresenius Medical Care AG & Co KGaA against its peers.

Discuss the investment returns and shareholder value creation
comparing Fresenius Medical Care AG & Co KGaA with its peers.

Analyze the financial leverage
of Fresenius Medical Care AG & Co KGaA compared to its main competitors.

Show all profitability ratios
for Fresenius Medical Care AG & Co KGaA.

Provide ROE
for Fresenius Medical Care AG & Co KGaA.

Provide ROA
for Fresenius Medical Care AG & Co KGaA.

Provide ROIC
for Fresenius Medical Care AG & Co KGaA.

Provide ROCE
for Fresenius Medical Care AG & Co KGaA.

Provide Gross Margin
for Fresenius Medical Care AG & Co KGaA.

Provide Operating Margin
for Fresenius Medical Care AG & Co KGaA.

Provide Net Margin
for Fresenius Medical Care AG & Co KGaA.

Provide FCF Margin
for Fresenius Medical Care AG & Co KGaA.

Show all solvency ratios
for Fresenius Medical Care AG & Co KGaA.

Provide D/E Ratio
for Fresenius Medical Care AG & Co KGaA.

Provide D/A Ratio
for Fresenius Medical Care AG & Co KGaA.

Provide Interest Coverage Ratio
for Fresenius Medical Care AG & Co KGaA.

Provide Altman Z-Score Ratio
for Fresenius Medical Care AG & Co KGaA.

Provide Quick Ratio
for Fresenius Medical Care AG & Co KGaA.

Provide Current Ratio
for Fresenius Medical Care AG & Co KGaA.

Provide Cash Ratio
for Fresenius Medical Care AG & Co KGaA.

What is the historical Revenue growth
over the last 5 years for Fresenius Medical Care AG & Co KGaA?

What is the historical Net Income growth
over the last 5 years for Fresenius Medical Care AG & Co KGaA?

What is the current Free Cash Flow
of Fresenius Medical Care AG & Co KGaA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Fresenius Medical Care AG & Co KGaA.

Business Breakdown

Fresenius Medical Care AG & Co KGaA emerged as a global leader in providing products and services for individuals undergoing dialysis, primarily due to chronic kidney disease (CKD). Founded in 1996 and headquartered in Bad Homburg, Germany, the company operates in over 120 countries, serving millions of patients while showcasing a commitment to innovation in renal care. By combining advanced medical technologies with a robust network of outpatient dialysis clinics, Fresenius has positioned itself as a vital player in the healthcare sector. Its commitment to high-quality patient care and effective treatment solutions not only sets it apart but also aligns with the increasing global demand for...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Fresenius Medical Care AG & Co KGaA

Current Assets 8.7B
Cash & Short-Term Investments 1.4B
Receivables 4.1B
Other Current Assets 3.2B
Non-Current Assets 25.2B
Long-Term Investments 1.4B
PP&E 7.3B
Intangibles 16.2B
Other Non-Current Assets 409.6m
Current Liabilities 5.9B
Accounts Payable 783.7m
Short-Term Debt 322m
Other Current Liabilities 4.8B
Non-Current Liabilities 14B
Long-Term Debt 10.3B
Other Non-Current Liabilities 3.7B
Efficiency

Earnings Waterfall
Fresenius Medical Care AG & Co KGaA

Revenue
19.4B EUR
Cost of Revenue
-14.5B EUR
Gross Profit
4.9B EUR
Operating Expenses
-3.6B EUR
Operating Income
1.4B EUR
Other Expenses
-828.5m EUR
Net Income
530.3m EUR

Free Cash Flow Analysis
Fresenius Medical Care AG & Co KGaA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Fresenius Medical Care reported a solid 2% organic revenue growth in Q3, highlighting improved performance in both Care Delivery and Care Enablement despite a slight 0.7% revenue drop due to divestitures. Operating income rose by 10%, achieving a margin of 9.8% as they move towards their 2025 target margin of 10-14%. The company confirmed their 2024 revenue guidance while accelerating their operating income growth forecast to 16-18%. The successful FME25 program yielded EUR 173 million in savings, exceeding their 2024 target. Despite external challenges, the overall outlook remains positive as the company continues to optimize operations and care delivery systems.

What is Earnings Call?
Fundamental Scores

FME Profitability Score
Profitability Due Diligence

Fresenius Medical Care AG & Co KGaA's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Positive Free Cash Flow
Positive Gross Profit
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
48/100
Profitability
Score

Fresenius Medical Care AG & Co KGaA's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

FME Solvency Score
Solvency Due Diligence

Fresenius Medical Care AG & Co KGaA's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
37/100
Solvency
Score

Fresenius Medical Care AG & Co KGaA's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

FME Price Targets Summary
Fresenius Medical Care AG & Co KGaA

Wall Street analysts forecast FME stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FME is 39.53 EUR with a low forecast of 22.23 EUR and a high forecast of 54.6 EUR.

Lowest
Price Target
22.23 EUR
47% Downside
Average
Price Target
39.53 EUR
6% Downside
Highest
Price Target
54.6 EUR
29% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for FME?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for FME is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

FME Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

FME News

Other Videos

Profile

Fresenius Medical Care AG & Co KGaA

Country

Germany

Industry

Health Care

Market Cap

12.4B EUR

Dividend Yield

2.82%

Description

Fresenius Medical Care AG & Co. KgaA provides products and services for individuals with renal diseases. The company is headquartered in Bad Homburg Vor Der Hohe, Hessen and currently employs 122,909 full-time employees. The firm provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The firm also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The firm supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.

Contact

HESSEN
Bad Homburg vor der Hohe
Else-Kroener-Strasse 1
+4961726090.0
www.freseniusmedicalcare.com

IPO

1996-10-02

Employees

122 909

Officers

Chair of Management Board & CEO
Ms. Helen Giza
CFO & Member of the Management Board
Mr. Martin Fischer
Global Chief Medical Officer & Member of Management Board
Dr. Franklin W. Maddux F.A.C.P.
CEO of Care Enablement & Member of Management Board
Dr. Katarzyna Mazur-Hofsab Ph.D.
CEO of Care Delivery & Member of Management Board
Mr. Craig Cordola FACHE, M.B.A., M.H.A.
Executive VP and Head of Investor Relations, Strategic Development & Communications
Dr. Dominik Heger
Show More
Global Head of Legal, Compliance & Human Resources and Labor Director
Mr. Jorg Haring
Senior Vice President of Corporate Communications & Governmental Affairs
Mr. Joachim Weith
Senior Vice President of Research & Development
Dr. Gail-Suzanne Brown
Senior Vice President of Manufacturing and Supply Chain Operations
Mr. Glenn Slater
Show Less

See Also

Discover More
What is the Intrinsic Value of one FME stock?

The intrinsic value of one FME stock under the Base Case scenario is 80.86 EUR.

Is FME stock undervalued or overvalued?

Compared to the current market price of 42.25 EUR, Fresenius Medical Care AG & Co KGaA is Undervalued by 48%.

Back to Top